October 28, 2022 03:12 PM EDTUpdated October 31, 04:52 AM
Pharma
Manufacturing

Up­dat­ed: A short­age of amox­i­cillin is now be­ing re­port­ed by sev­er­al man­u­fac­tur­ers

Tyler Patchen

News Reporter

On­ly a few weeks af­ter the FDA rec­og­nized a short­age of Adder­all, an­oth­er cru­cial drug is in low sup­ply, this time the an­tibi­ot­ic amox­i­cillin …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Among phar­ma CEOs, the IRA now and the IRA lat­er get very dif­fer­ent re­ac­tions

Bris­tol My­ers restarts ra­dio­phar­ma­ceu­ti­cal Phase 3 tri­al, but de­lays read­out by one year

An­drew Left, short sell­er who cam­paigned against Valeant, is ac­cused of fraud by SEC

Up­dat­ed: With cost-cut­ting un­der­way, Bris­tol My­ers rais­es guid­ance, touts Phase 3 win and scraps an­oth­er

Eu­ro­pean drug reg­u­la­tor re­jects Alzheimer's drug Leqem­bi, cit­ing safe­ty con­cerns

sponsored

Crit­i­cal Junc­tures in Gene Ther­a­py Clin­i­cal Ma­te­r­i­al Man­u­fac­tur­ing: Where Do I Start? And Will It Work?

A service from the Financial Times